|
US2021093235A1
|
|
Use of additives, copolymers, and dopants for optical stability of analyte sensing components
|
|
US2021007780A1
|
|
Removal tool for a subcutaneous implantable device
|
|
US2020375511A1
|
|
Tailored drug delivery vehicles for in vivo protection of analyte sensing compounds
|
|
US2020359943A1
|
|
Mediation of in vivo analyte signal degradation
|
|
US2020359944A1
|
|
Interoperability validation in an analyte monitoring system
|
|
WO2020227555A1
|
|
Mediation of in vivo analyte signal degradation
|
|
US2020323557A1
|
|
Insertion tool with a dissector
|
|
WO2020172540A1
|
|
Mediation of in vivo analyte signal degradation
|
|
US2020178860A1
|
|
System and method for continuous and on-demand analyte monitoring
|
|
US2020178799A1
|
|
Multiple modes of transceiver operation in analyte monitoring system
|
|
US2020178856A1
|
|
Assessement of performance of an implanted sensor
|
|
US2020178855A1
|
|
Analyte level rate of change alerts in an analyte monitoring system
|
|
WO2020118027A1
|
|
Reduction of in vivo analyte signal degradation using multiple metals
|
|
US2020138350A1
|
|
Analyte monitoring systems and methods that make use of information about a condition of the environment surrounding an analyte sensor
|
|
WO2020092890A1
|
|
Environmental detection and/or temperature compensation in an analyte monitoring system
|
|
US2020138948A1
|
|
Drug eluting matrix on analyte indicator
|
|
WO2020056001A1
|
|
An analyte monitoring system
|
|
US2020054251A1
|
|
Mediated drug release for reducing in vivo analyte indicator degradation
|
|
US2019239784A1
|
|
Data management system communications with a display device in an analyte monitoring system
|
|
WO2019133618A1
|
|
User interface for time-sensitive event entry in analyte monitoring system
|
